Vltava Fund's Q2 2024 investor letter highlights CVS Health Corporation (NYSE:CVS) as a potential investment choice. The firm considers AI stocks more promising for higher returns in a shorter timeframe. CVS was added to Ariel Global Fund's portfolio in Q1 2024.